Company news

Teleflex Incorporated (NYSE:TFX) news

Teleflex Incorporated news releases on 6ix. Latest, Sep 29, 2026: Teleflex Announces Latest Peer-Reviewed Study Demonstrates a Significant Reduction in CLABSI…

Teleflex Incorporated (NYSE:TFX) news

Press releases & updates

Teleflex Announces Latest Peer-Reviewed Study Demonstrates a Significant Reduction in CLABSI Risk with Arrowg+ard™ Technology

Teleflex Appoints Veteran Medical Technology Executive Sean M. Salmon to Teleflex Board of Directors

Teleflex Features Innovative Dynetic™-35 Balloon-Expandable Cobalt Chromium Stent System at CIRSE 2026

Teleflex Incorporated : Q2 2026 Teleflex Incorporated Earnings Call Presentation

Teleflex Reports Second Quarter Financial Results and Full Year 2026 Outlook

Teleflex Medical OEM Launches as INGENYX to Empower Tomorrow’s MedTech Innovators

Teleflex Completes Strategic Divestiture of OEM Business for $1.5 Billion

Teleflex Announces FDA BLA Approval of EZPLAZ Freeze Dried Plasma

Teleflex Announces FDA BLA Approval of EZPLAZ™ Freeze Dried Plasma

Teleflex Announces Second Quarter 2026 Earnings Conference Call Information

Teleflex Awarded National Central Venous Access Agreement with Premier, Inc.

Teleflex Publishes 2025 Global Impact Report

Teleflex Initiates Enrollment in Global BIOMAG™‑III Pivotal Trial of Freesolve™ Resorbable Magnesium Scaffold

Teleflex Incorporated Announces Pricing of $500 Million Senior Notes Offering

Teleflex Incorporated Announces Private Offering of $500 Million of Senior Notes Due 2032

Teleflex Showcases New Clinical Data at Leading Urological Congresses Highlighting Patient Experience Advantages of the UroLift™ System and Long-Term Toxicity Reduction with Barrigel™ Rectal Spacer

Teleflex Reports First Quarter Financial Results and Full Year 2026 Outlook

Teleflex Appoints Jason Weidman as President and CEO

Teleflex Announces First Quarter 2026 Earnings Conference Call Information

Teleflex Announces Governance Updates

Teleflex Reiterates Commitment to Value Maximizing Strategies and Strong Execution

o9 Announces Teleflex™ Global Go-Live for Integrated Demand and Supply Planning

Teleflex Reports 2025 Financial Results and Full Year 2026 Outlook

Teleflex Announces Fourth Quarter 2025 Earnings Conference Call Information

Teleflex Announces Leadership Transition

Teleflex Announces Sale of Acute Care, Interventional Urology, and OEM Businesses for $2.03 Billion

Teleflex to Present at the Jefferies Global Healthcare Conference in London

Teleflex Announces Quarterly Dividend

Teleflex Reports Third Quarter Financial Results and Full Year 2025 Outlook

Teleflex Announces Third Quarter 2025 Earnings Conference Call Information and Vascular Intervention Investor Virtual Meeting Details

First Patient Enrolled in DUBSTENT DIABETES Trial: Targeting Improved PCI Outcomes for Diabetic Patients

Teleflex to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference

Teleflex Announces the Launch of Barrigel™ Rectal Spacer in Japan as a Proven Safe and Effective Option to Minimize the Harmful Long-Term Side Effects of Prostate Radiation Therapy

Teleflex Reports Second Quarter Financial Results and Full Year 2025 Outlook

Teleflex Announces Second Quarter 2025 Earnings Conference Call Information

Teleflex Completes Acquisition of BIOTRONIK’s Vascular Intervention Business

New Prospective Cohort Study Reporting the Efficacy of Arrow™ Chlorhexidine-Impregnated Central Venous Catheters Demonstrates Reduced Infection Rates Among ICU Patients

Teleflex Highlights Prostate Health and Quality-of-Life Awareness Through Two Key Public Initiatives During Men’s Health Month

Teleflex Publishes 2024 Global Impact Report

Teleflex Showcases New Clinical Data Presented at the 2025 American Urological Association (AUA) Annual Meeting

New Retrospective Study Reports Significantly Reduced Post-Operative GERD Rates with the Titan SGS™ Stapler from Teleflex Compared with Multi-Fire Staplers in Sleeve Gastrectomy

Teleflex Reports First Quarter Financial Results and Full Year 2025 Outlook

Teleflex to Present at the BofA Securities 2025 Health Care Conference

Teleflex receives FDA 510(k) Clearance for Expanded Indications of the QuikClot Control+™ Hemostatic Device

Teleflex Announces Clinical and Real-World Evidence Studies and Physician Educational Opportunities to Be Highlighted at the 2025 American Urological Association (AUA) Annual Meeting

Teleflex Announces First Quarter 2025 Earnings Conference Call Information

Teleflex Receives FDA 510(k) Clearance of the AC3 Range™ Intra-Aortic Balloon Pump (IABP)

Preliminary Results from IDE Study on Ringer™ Perfusion Balloon Catheter (PBC) Reported from Podium at CTO Plus Conference

Teleflex Announces Updated Clinical Study Data Presented at the European Association of Urology (EAU) Congress

Teleflex Reports Fourth Quarter and Full Year 2024 Financial Results